| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/05/2011 | EP2269656A2 Selected antibodies binding to anionic phospholipids and aminophospholipids and their use in treatment |
| 01/05/2011 | EP2269636A2 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 01/05/2011 | EP2269635A1 Enterococcus antigens and vaccines |
| 01/05/2011 | EP2269634A2 Antigenic polypeptides |
| 01/05/2011 | EP2269632A2 Immunostimulatory compositions and methods of stimulating an immune response |
| 01/05/2011 | EP2269626A2 Protective proteins of S. agalactiae, combinations thereof and methods of using the same |
| 01/05/2011 | EP2269625A2 Protective proteins of S. agalactiae, combinations thereof and methods of using the same |
| 01/05/2011 | EP2269624A2 Protective proteins of S. agalactiae, combinations thereof and methods of using the same |
| 01/05/2011 | EP2269597A1 CLEC-2 is an essential platelet activating receptor in hemostasis and thrombosis |
| 01/05/2011 | EP2269071A1 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma |
| 01/05/2011 | EP2268812A1 Inhibitors of stim1 for the treatment of cardiovascular disorders |
| 01/05/2011 | EP2268672A1 Anti-tyrp1 antibodies |
| 01/05/2011 | EP2268671A1 Novel antibodies used to treat cancer |
| 01/05/2011 | EP2268670A1 Glucagon receptor antagonists |
| 01/05/2011 | EP2268669A1 Immuno-modulating compositions for the treatment of immune-mediated disorders |
| 01/05/2011 | EP2268668A1 Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same |
| 01/05/2011 | EP2268659A2 Mutant forms of chlamydia htra |
| 01/05/2011 | EP2268310A1 Use of a type ii anti-cd20 antibody with increased antibody dependent cellular cytotoxicity (adcc) in combination with cyclophosphamide, vincristine and doxorubicine for treating non-hodgkin' s lymphomas |
| 01/05/2011 | EP2268296A1 Compositions and method for the diagnosis, prevention and treament of alzeimer's disease |
| 01/05/2011 | EP2069404B1 Humanized anti-cd100 antibodies |
| 01/05/2011 | EP1875237B1 Docetaxel immunoassay |
| 01/05/2011 | EP1720572B1 Monovalent ligand of the fcalphari receptor as an anti-inflammatory agent |
| 01/05/2011 | EP1603941B1 Inhibitors of extracellular hsp90 |
| 01/05/2011 | EP1546182B1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/05/2011 | EP1493034B1 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1 immunoreactivity |
| 01/05/2011 | EP1485415B1 Neoplasm specific antibodies and uses thereof |
| 01/05/2011 | EP1482964B1 Use of egfr transactivation inhibitors in human cancer |
| 01/05/2011 | EP1463806B1 Novel cyclooxygenase variants and methods of use |
| 01/05/2011 | EP1401467B1 Alpha-fetoprotein peptides and uses thereof |
| 01/05/2011 | EP1294769B1 Antibodies that immunospecifically bind to blys |
| 01/05/2011 | EP0815129B1 Ingap protein involved in pancreatic islet neogenesis |
| 01/05/2011 | CN1878562B Antibody therapy |
| 01/05/2011 | CN1802388B CD20-specific antibodies and methods of employing same |
| 01/05/2011 | CN101939425A Anti-IL-6 receptor antibody |
| 01/05/2011 | CN101939424A Anti-nr10 antibody and use thereof |
| 01/05/2011 | CN101939339A Biomarker detection |
| 01/05/2011 | CN101939338A 1b20 pcsk9 antagonists |
| 01/05/2011 | CN101939337A Anti-TRKA antibodies and derivatives thereof |
| 01/05/2011 | CN101939336A AXL antibodies |
| 01/05/2011 | CN101939335A Antigen-binding polypeptides against cartilage degeneration |
| 01/05/2011 | CN101939334A Hepatitis c virus antibodies |
| 01/05/2011 | CN101939333A Non-aggregating human VH domains |
| 01/05/2011 | CN101939025A Therapeutic agent for pruritus |
| 01/05/2011 | CN101936986A Method for detecting diazepam and chemoluminescence immunoassay kit special for same |
| 01/05/2011 | CN101936985A Method for detecting diethylstilbestrol and special chemiluminescent immunoassay kit thereof |
| 01/05/2011 | CN101936984A Method and special chemical luminous immunoassay kit for detecting clenbuterol |
| 01/05/2011 | CN101936983A Method for detecting sulfonamide compound and special quantum dot fluorescent immune kit thereof |
| 01/05/2011 | CN101935675A Construction and application of cell membrane expression ALV-env fluorescin eukaryotic transgenic expression plasmid |
| 01/05/2011 | CN101935352A Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
| 01/05/2011 | CN101935350A Disulfide-stabilized anti-chloramphenicol single-chain antibody as well as construction method and application thereof |
| 01/05/2011 | CN101935349A Humanized monoclonal antibody against human vascular endothelial growth factor and preparation and application thereof |
| 01/05/2011 | CN101935348A Lead ion antigen and preparation method and application thereof |
| 01/05/2011 | CN101935340A Prokaryotic expression protein of ORSV (Odontoglossum Ring Spot Virus) coat protein gene as well as preparation method and application thereof |
| 01/05/2011 | CN101935338A Reticuloprotein epitope, anti-reticuloprotein antibody and application thereof |
| 01/04/2011 | US7863433 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 01/04/2011 | US7863426 Antibody purification |
| 01/04/2011 | US7863425 Yersina virulence antigen specific monoclonal antibody for use in prevention of plague; prevention of bioterrorism; directed protein evolution |
| 01/04/2011 | US7863424 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 01/04/2011 | US7863423 polynucleotides and polypeptides which are under-expressed in cancer and dysplasia delivered therapeutically to reduce the abnormal characteristics of cancer and dysplastic cells |
| 01/04/2011 | US7863422 monoclonal antibody inhibits CD4+ T cell, NK cell proliferation, as antiinflammatory agents in the therapeutic treatment and diagnostic detection of immune disorders in mammals; biodrugs |
| 01/04/2011 | US7863419 Antibodies having altered effector function and methods for making the same |
| 01/04/2011 | US7863418 T cell immune response cDNA 7 (TIRC7) protein for use in treatment of organ transplantation rejection, tumor, autoimmune and/or allergic disorders |
| 01/04/2011 | US7863411 Comprises polypeptide, protein and/or peptide which recognize and bind to prion envelope protein for use as diagnostic tool in detecting spongiform encephalopathies; screening and removing prions from fluid products; preventing viral infection |
| 01/04/2011 | US7863011 Screening at least one individual for a mutation in a gene coding for a Poly-Ig (Fc) receptor or a Poly-Ig-like (Fc) receptor capable of mediating inhibition of cancer cell growth by an immunoglobulin inhibitor |
| 01/04/2011 | US7863009 Mutants of the factor VII-activating protease and detection methods using specific antibodies |
| 01/04/2011 | US7863006 Monoclonal antibody for use in detection of spongiform encephalopathy and brain disorders |
| 01/04/2011 | US7863005 Using cochlin isoform as screening tool for diagnosis/prognostication of hearing disorders |
| 01/04/2011 | US7862994 Preventing fusion of virus and preferential cells; incubate cells with genetically engineered viral particles and viricide, detect reduction in emission energy, reduction in emission indicates prevention of viral fusion and infection |
| 01/04/2011 | US7862820 Immunoglobulin chimeric monomer-dimer hybrids |
| 01/04/2011 | US7862818 Using chemokine specific immunoglobulin to prevent and treat inflammatory bowel disease, colitis and/or sarcoidosis |
| 01/04/2011 | US7862817 Kit to treat ErbB2-expressing cancer in patient; humanized version of monoclonal antibody 2C4; immunoconjugate of humanized antibody conjugated with a cytotoxic agent; patient produces a greater than normal level of ErbB ligand epidermal growth factor, transforming growth factor alpha |
| 01/04/2011 | US7862816 Identifying ephrin inhibitors for use in treatment and prevention of cell proliferative and angiogenesis disorders; antitumor agents |
| 01/04/2011 | US7862815 Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP) |
| 01/04/2011 | US7862814 Method of inhibiting the proliferation of B cell cancers using TACI-immunoglobulin fusion proteins |
| 01/04/2011 | CA2487060C Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency |
| 01/04/2011 | CA2459013C Proteins having effects of controlling cell migration and cell death |
| 01/04/2011 | CA2406240C Hcv anti-core monoclonal antibodies |
| 01/04/2011 | CA2341239C A preventive or therapeutic agent for pancreatitis comprising il-6 antagonist as an active ingredient |
| 01/04/2011 | CA2285018C Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 01/04/2011 | CA2283754C Use of avian antibodies |
| 01/04/2011 | CA2279474C Novel antibody composition for debulking blood and bone marrow samples from cml patients |
| 01/04/2011 | CA2268865C Anti-p53 single-chain antibody fragments and their uses |
| 01/04/2011 | CA2246744C Immunomodulatory complex and use thereof in diseases caused by helicobacter |
| 01/04/2011 | CA2163439C Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/04/2011 | CA2142575C Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma |
| 01/04/2011 | CA2101774C Test and model for alzheimer's disease |
| 01/04/2011 | CA2068654C Varicella-zoster virus antigen |
| 12/30/2010 | US20100331537 Novel surface antigen |
| 12/30/2010 | US20100331536 CA125 gene and its use for diagnostic and therapeutic interventions |
| 12/30/2010 | US20100331528 Isolated Antibodies Against Biologically Active Leptin-Related Peptides |
| 12/30/2010 | US20100331527 Readily Isolated Bispecific Antibodies with Native Immunoglobulin Format |
| 12/30/2010 | US20100331526 Capture purification processes for proteins expressed in a non-mammalian system |
| 12/30/2010 | US20100331251 Polypeptides homologous to vegf and bmp1 |
| 12/30/2010 | US20100331250 Anti-angiogenesis fusion proteins |
| 12/30/2010 | US20100331208 Cell Display Of Antibody Libraries |
| 12/30/2010 | US20100331206 Compositions and methods for early pregnancy diagnosis |
| 12/30/2010 | US20100331193 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 12/30/2010 | US20100330657 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 12/30/2010 | US20100330617 Methods of Producing a Secreted Protein |
| 12/30/2010 | US20100330595 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |